The Companies and Markets Show: The 2023 Aim special

episode

Investors' Chronicle not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-29-2026 7AM EDT 4 min · 29 Sep 2026 · NPR News Now

7AM ET 09/29/2026 Newscast 3 min · 29 Sep 2026 · Fox News Hourly Update

Most replayed moment: The hidden dangers of hearing loss | Prof. Marcelo Rivolta 8 min · 29 Sep 2026 · ZOE Science & Nutrition

Overmedicated To Death: Former FDA Officer on Presley Gerber & The Psychiatric Crisis in America w/ Dr. Mary Talley Bowden, Dr. Josef Witt-Doerring & Ronald Owens Jr. – Ask Dr. Drew – Ep 670 1h 19m · 29 Sep 2026 · Ask Dr. Drew

Federal boost for Navitas 6 min · 29 Sep 2026 · Wall Street Breakfast

SpaceX Starship Finally Reached Orbit & Why Dudes Are Becoming Cat Dads 29 min · 29 Sep 2026 · Morning Brew Daily

Report any issue

Source

Recorded20 Oct 2023

Publisherfeeds.acast.com ↗

Handlerec:10067514

Show notes

This week’s episode, like this week’s cover feature special, highlights the first part of our annual dive into the top 100 Aim companies. Having had a nightmarish 2022, companies traded on the alternative market don’t seem to have had an easier time in 2023 as the index underperformed the FTSE All-Share and the FTSE Small Cap Index. Our journalists have analysed the top 100 Aim companies and, in this episode, you can hear a handful of the team discuss some cherrypicked businesses. These firms include investment manager Tatton Asset Management, specialist franchiser Franchise Brands, insolvency expert FRP Advisory and antibody producer Bioventix. Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in